The SV-40 virus that contaminated the oral polio vaccine quickly spread from child to child and from child to adult, crossing state lines and national boundaries. By 1960, when the virus was first detected, it was already too late to prevent its dissemination throughout the population. The FDA quietly and gradually instituted a program to eliminate rhesus monkeys, who harbor the SV-40, and replace them with African Green monkeys that are free of the virus. By 1963 the monkeys had been replaced but the estimated number of tainted polio vaccinations was estimated to be 98-million!
According to the National Institutes of Health, high levels of SV-40 were identified in polio vaccines in Washington, Oregon, Wyoming, Utah, Minnesota, Iowa, Wisconsin, Illinois, Michigan, Pennsylvania, Washington DC, Maryland, Delaware, New York, Connecticut, Rhode Island, Massachusetts, Vermont and New Hampshire. Low
levels of SV-40 were found in California, Arizona, New Mexico, Colorado, Texas, Kansas, Nebraska, North Dakota, Missouri, Louisiana, Georgia, Tennessee, Kentucky, Ohio, and West Virginia.
Polio vaccines in the other states show no SV-40 present.This revelation has only recently come to public attention. Many people, like myself, were unaware that a potential for cancer had been implanted in their body. Researchers say that, by age fifteen, the virus stops shedding to others. I cannot but wonder how many people I contacted between the age of eight and fifteen... Did I shed the SV-40 virus to my mother, who eventually died of brain cancer? Will I contract brain, lung or bone cancer? Many other people in my age group are asking similar questions.
A number of public statements have been made by the National Cancer Institute in the past few months, attempting to put their spin on these disturbing revelations. In an statement published in the January (1999) New England Journal of Medicine, the institute states that there is no evidence of an increase in humans of the types of cancers found in laboratory animals that have been injected with SV-40. But other researchers remind us that SV-40 has already been found in a wide variety of other tumors. It has been shown that individuals who received the tainted oral vaccine demonstrate a higher occurrence of these cancers.
For example: people who lived in Massachusetts and Illinois in the 1950s, and received identified lot numbers of the contaminated oral vaccine, are now contracting osteosarcoma bone tumors at a rate of ten times more than those who received the vaccine free of the SV-40. But the National Cancer Institute has been silent about these facts.
There needs to be more demographic studies to explore the relationship of SV-40 to adult onset cancers. Not surprisingly, the US government and its agencies are reluctant to pursue this matter. In fact, requests to the National Institute for Health for grants to study the SIV and simian cyto-megalovirus (SCMV) were recently denied. Microbiologist Howard Urnovitz, Ph.D., may have an explanation as he stated in the Boston Globe:
"that almost 100 million Americans were exposed (to SV-40) through a government sponsored program, but for over 30 years, there has been virtually no government effort to see if anyone's been harmed by the exposure." He added, "The government will not fund science that makes it look culpable."
Another method used by the National Cancer Institute to divert public concern is to issue statements that "many of the cancers under suspicion were contracted by people who are too young to have received the tainted vaccine in the 1950s." This argument, although true, ignores the potential of spreading the live SV-40 by "shedding" through personal contact. The oral polio vaccine was designed to be transmitted to non-vaccinated individuals by this very method. In fact, this was the reason that OPV was preferred over injection. If SV-40 is still being spread by contact today it is not surprising that these cancers are now affecting younger people.
Regardless of blame, severe damage to world health has already been done by the unsavory practice of growing vaccination products in animals. An example of these horrors was presented by Dr. Urnovitz at the Eighth Annual Houston Conference on AIDS.
Dr. Urnovitz revealed significant evidence that human immunodeficiency virus type 1 (HIV-1) is a monkey hybrid virus which was produced when 320,000 Africans were injected with polio virus contaminated with live simian immunodeficiency virus (SIV) in the late 1950's. Apparently, viral fragments combine easily with other viruses to produce these hybrids called "chimeras." Prior to this revelation, health officials were blaming AIDS on the habit of certain Africans to consume monkey flesh.
What can be done now? "Make it in anything but animals," said Barbara Loe Fisher of the National Vaccine Information Center, which criticizes vaccine safety.
"We have the technology to make vaccines in human cell lines that are clean," said Dr. Michele Carbone of Loyola University Medical Center, one of the first to discover SV-40 inside human tumors.
Until then we can only hope that researchers continue their work, regardless of the repercussions. Millions of people are already infected with SV-40 and are in danger. Many cancers do not develop until mid-life. Future generations must be protected. We must prohibit any future contamination of the world population, whether for our own good or not, by well-meaning governmental agencies.
UPDATE: October-November 2002 -- The following article appeared in the NY Times on October 22, 2002, partially quoted as follows:
Monkey Virus - Cancer Link Debated (THE ASSOCIATED PRESS)
WASHINGTON (AP) -- Despite years of study, there remains too little
evidence to conclude a monkey virus that once tainted some polio
vaccine can cause cancer in humans.
Still, the Institute of Medicine said Tuesday, although studies of
people who received the vaccine have not shown increased cancer rates, a connection cannot be completely ruled out.
The institute, an arm of the National Academy of Sciences, recommended
development of a federal response plan for dealing with contaminated
vaccines and better tests for the monkey virus to determine how
widespread it is.
The test in this article was to compare the group of people who got the original "live" virus in the 1950's, in school immunization programs, with the cancer rates of the general population. But, remember, the whole purpose of the mandatory "live" virus immunization program was to make sure that EVERYONE was exposed to the new batches of vaccine. This was done by having innoculated children "shed" the virus to others -- their parents, other children and virtually anyone that had contact with them after they were vaccinated. In other words, the entire American population was subjected to the SV-40 in either the original innoculation or from the shedding. So it is natural that the rates of cancer would be no different between the school children and anyone else that they infected.
On the whole, cancer rates have sky-rocketed, especially those rare forms related to the SV40, yet this type of misleading (i.e. lies) is typical of what the current administration and Federal offices are attempting to do with everything from the threat of Iraq to the infecting of its own population in the past.
If you want to get involved in a potential class action suit, you might want to contact a woman whose daughter contracted one of these rare forms of cancer (medulloblastoma), attributed to the SV40 contamination. Not only does she suffer from having her child impacted by this horrible governmental error, but she also has the uncertain guilt of possibly infecting her daughter from her own exposure to the live virus back in the 1950s.
Maybe you have had a similar experience. Are you angry? Then contact Sandy at firstname.lastname@example.org. Remember the words of Mahatma Gandhi: "Even if you are a minority of one, the truth is still the truth."
UPDATE ON VACCINE MISTAKES:
Rotarix rotavirus vaccine contaminated, officials say!
(CNN) (March 2010) Federal health authorities recommended Monday that doctors suspend using Rotarix, one of two vaccines licensed in the United States against rotavirus, saying the vaccine is contaminated with material from a pig virus.
"There is no evidence at this time that this material poses a safety risk," Food and Drug Administration Commissioner Dr. Margaret Hamburg told reporters in a conference call.
Rotarix, made by GlaxoSmithKline, was approved by the FDA in 2008. The contaminant material is DNA from porcine circovirus 1, a virus from pigs that is not known to cause disease in humans or animals, Hamburg said.
About 1 million children in the United States and about 30 million worldwide have gotten Rotarix vaccine, she said.
Rotavirus disease kills more than 500,000 infants around the world each year, primarily in low- and middle-income countries, she said. Before rotavirus vaccine became available, the disease was blamed for more than 50,000 hospitalizations and several dozen deaths per year in the United States, she said.
The FDA learned about the contamination after an academic research team using a novel technique to look for viruses in a range of vaccines found the material in GlaxoSmithKline's product and told the company, Hamburg said. The drug maker confirmed its presence in both the cell bank and the seed from which the vaccine is derived, suggesting its presence from the early stages of vaccine development, she said. The FDA then confirmed the drug maker's findings.
GlaxoSmithKline emphasized Monday that the pig virus is not known to cause illness in humans, saying "it is found in everyday meat products and is frequently eaten with no resulting disease or illness."
"No safety issue has been identified by external agencies or GSK," Thomas Breuer, the drug maker's chief medical officer, said in a written statement. "GSK is committed to patient safety and to the highest manufacturing standards for all our vaccines and medicines. We are already working closely and discussing this finding with regulatory agencies around the world."
Another vaccine, RotaTeq, is made by Merck and was approved in 2006. There is no evidence that the Merck product is affected, Hamburg said. Both vaccines are given by mouth to infants to prevent rotavirus disease, which is marked by severe diarrhea and dehydration.
Asked whether Merck would be able to meet the nation's demand, Merck spokeswoman Pam Eisele said, "Obviously, we will work with the ... FDA to evaluate supply needs."
In the next four to six weeks, the drug agency will convene an advisory committee to make recommendations and seek input on the use of new techniques for identifying viruses in vaccine, Hamburg said.
"We're not pulling it from the market, we're just suspending its use during this period while we're collecting more information," she said. "It should not be in this vaccine product and we want to understand how it got there. It's not an easy call and we spent many long hours debating the pros and cons but, because we have an alternative product and because the background rates of this disease are not so severe in this country, we felt that the judicious thing to do was to take a pause, to really ask the critical questions about what this material was doing in the vaccine, how it got there."
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, said "a substantial amount" of the DNA was found in the vaccine. But, he stressed, "there is no evidence that it causes any disease. ... There is no evidence that it ever does anything."
The research group that discovered the contamination has asked not to be identified pending its paper's publication in a scientific journal, Hamburg said.
Anyone who has already received a dose of Rotarix should switch to the Merck product for the next two doses, Hamburg said. Preliminary testing of the Merck product has found no evidence of the porcine circovirus 1 DNA, she said. Doctors should be able to tell parents which of the two products their children received, she said.
Hamburg stressed that the suspension applies only to the United States. Public health officials in countries where the incidence of rotavirus is more severe may decide that the benefits of continuing to use the vaccine outweigh any concerns raised by the contamination, she said. "Such a decision would be very understandable," she added.
A similar virus, porcine circovirus 2, also does not cause disease in humans, but it does cause disease in its pig host, Hamburg said.